Sharps Technology Inc. Contracts & Agreements
66 Contracts & Agreements
- Business Finance (41 contracts)
- Business Operations (5)
- Human Resources (10)
- Mergers & Acquisitions (1)
- Uncategorized (9)
- Form of the Warrant (Filed With SEC on September 23, 2024)
- Form of the Placement Agent Agreement (Filed With SEC on September 23, 2024)
- Form of Registration Rights Agreement (Filed With SEC on September 23, 2024)
- Form of Senior Secured Note (Filed With SEC on September 23, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on September 23, 2024)
- Supply Agreement, dated July 24, 2024, by and among Sharps Technology, Inc. and Stericare Solutions, LLC (Filed With SEC on July 25, 2024)
- Form of Warrant Inducement Agreement by and between Sharps Technology, Inc. and Holder(s) (Filed With SEC on May 30, 2024)
- Form of New Warrant (Filed With SEC on May 30, 2024)
- Amendment No. 1 to Purchase Agreement dated September 22, 2023 by and between the Company and Nephron Pharmaceuticals, Inc (Filed With SEC on May 24, 2024)
- Purchase Agreement dated May 6, 2024, by and between the Company and Nephron Pharmaceuticals, Inc (Filed With SEC on May 24, 2024)
- Logistic Service Agreement dated March 8, 2024 by and between the Company and Owens & Minor Distribution, Inc (Filed With SEC on March 8, 2024)
- Amendment to Cooperative Sales and Distribution Agreement (Filed With SEC on March 8, 2024)
- Cooperative Sales and Distribution Agreement dated March 1, 2024 by and between the Company and Roncadelle Operations s.r.l (Filed With SEC on March 8, 2024)
- Sharps Technology, Inc. Amended and Restated 2023 Equity Incentive Plan (Filed With SEC on December 20, 2023)
- Employment Agreement with Robert Hayes dated Novermber 10, 2023 (Filed With SEC on November 14, 2023)
- Form of the PIPE Pre-Funded Warrant (Filed With SEC on October 3, 2023)
- Form of the PIPE Securities Purchase Agreement, dated September 27, 2023 (Filed With SEC on October 3, 2023)
- Form of the RD Securities Purchase Agreement, dated September 27, 2023 (Filed With SEC on October 3, 2023)
- Form of the Registration Rights Agreement, dated September 27, 2023 (Filed With SEC on October 3, 2023)
- Form of the Placement Agent Agreement, dated September 27, 2023 (Filed With SEC on October 3, 2023)
- Form of the Warrant (Filed With SEC on October 3, 2023)
- Form of the RD Pre-Funded Warrant (Filed With SEC on October 3, 2023)
- Purchase Agreement dated September 22, 2023 by and between the Company and Nephron Pharmaceuticals, Inc (Filed With SEC on September 26, 2023)
- Asset Purchase Agreement dated September 22, 2023 by and between the Company and Nephron Pharmaceuticals, Inc (Filed With SEC on September 26, 2023)
- Form of the Warrant (Filed With SEC on February 6, 2023)
- Form of the Placement Agent Agreement, dated February 1, 2023 (Filed With SEC on February 6, 2023)
- Form of the Registration Rights Agreement, dated February 1, 2023 (Filed With SEC on February 6, 2023)
- Form of the PIPE Securities Purchase Agreement, dated February 1, 2023 (Filed With SEC on February 6, 2023)
- 2023 Equity Incentive Plan (Filed With SEC on January 27, 2023)
- Distribution Agreement, dated December 8, 2022, by and among Sharps Technology, Inc., Nephron Pharmaceuticals Corporation and Nephron SC, Inc (Filed With SEC on December 13, 2022)
- Employment Agreement, dated September 30, 2022, by and between Sharps Technology, Inc., and Andrew R. Crescenzo (Filed With SEC on October 6, 2022)
- Agreement, dated September 29, 2022, by and among Sharps Technology, Inc., InjectEZ, LLC, Nephron Pharmaceuticals Corporation, Nephron SC, Inc. and Nephron Sterile Compounding... (Filed With SEC on October 4, 2022)
- Employment Agreement between the Company and Alan R. Blackman dated August 1, 2022 (Filed With SEC on August 15, 2022)
- Amendment to Asset/Share Purchase Agreement, dated April 13, 2022 (Filed With SEC on April 19, 2022)
- Warrant Agent Agreement between the Company and VStock Transfer, LLC (Filed With SEC on April 19, 2022)
- Underwriting Agreement, dated as of April 13, 2022 (Filed With SEC on April 19, 2022)
- Form of Warrant Agent Agreement (Warrants) (Filed With SEC on April 7, 2022)
- Form of Warrant Agent Agreement (Pre-Funded Warrants) (Filed With SEC on April 7, 2022)
- Form of Warrant for this offering (Filed With SEC on April 7, 2022)
- Form of Underwriting Agreement (Filed With SEC on April 7, 2022)
- Form of Representatives Warrant (Filed With SEC on April 5, 2022)
- Form of Warrant Agent Agreement (Warrants) (Filed With SEC on April 5, 2022)
- Plan and Agreement of Merger, dated March 22, 2022, between Sharps Technology, Inc., a Wyoming corporation, and Sharps Technology, Inc., a Nevada corporation (Filed With SEC on April 5, 2022)
- 2022 Equity Incentive Plan (Filed With SEC on March 30, 2022)
- Form of Pre-Funded Warrant for this offering (Filed With SEC on March 30, 2022)
- Form of Warrant Agent Agreement (Filed With SEC on March 30, 2022)
- Amendment No. 5 to Asset/Share Purchase Agreement, dated February 28, 2022 (Filed With SEC on March 18, 2022)
- Form of Underwriting Agreement (Filed With SEC on March 18, 2022)
- Form of Warrant for this offering (Filed With SEC on March 18, 2022)
- Asset/Share Purchase Agreement, dated June 10, 2020, among the Company, Safegard Medical (Hungary) Ktf,, Numan Holding Ltd, Cortrus Services SA and Latitude Investments Limited (Filed With SEC on March 18, 2022)
- Amendment No. 1 to Asset/Share Purchase Agreement, dated June 24, 2020 (Filed With SEC on March 18, 2022)
- Amendment No. 2 to Asset/Share Purchase Agreement, dated August 27, 2020 (Filed With SEC on March 18, 2022)
- Amendment No. 3 to Asset/Share Purchase Agreement, dated October 28, 2020 (Filed With SEC on March 18, 2022)
- Amendment No. 4 to Asset/Share Purchase Agreement, dated July 19, 2021 (Filed With SEC on March 18, 2022)
- Letter, dated September 23, 2021, from Numan Holding Ltd (Filed With SEC on March 18, 2022)
- Employment Agreement, dated September 9, 2021, between the Company and Robert Hayes (Filed With SEC on March 18, 2022)
- Consulting Agreement between the Company and Alan Blackman (Filed With SEC on March 18, 2022)
- Amended Consulting Agreement, dated May 28, 2019, between the Company and Barry Berler (Filed With SEC on March 18, 2022)
- Royalty Agreement, dated July 11, 2017, between Alan Blackman and Barry Berler (Filed With SEC on March 18, 2022)
- Amendment to Royalty Agreement, dated September 4, 2018 (Filed With SEC on March 18, 2022)
- Consulting Agreement, dated January 1, 2021, between the Company and Berry Berler (Filed With SEC on March 18, 2022)
- Note Purchase Agreement, dated December 14, 2021, among the Company and the purchasers named therein (Filed With SEC on March 18, 2022)
- Form of Note (Filed With SEC on March 18, 2022)
- Security Agreement among the Company and the secured parties named therein (Filed With SEC on March 18, 2022)
- Consent to be named as a director nominee of Jason Monroe (Filed With SEC on March 18, 2022)
- Consent to be named as a director nominee of Brenda Baird Simpson (Filed With SEC on March 18, 2022)
